I4V-MC-JAHW - ClinicalTrials.gov - NCT04088409
I4V-MC-JAHW - ClinicalTrials.gov - NCT04088409
Key Requirements
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Participants must
Participants must have a diagnosis of JIA-U or chronic anterior antinuclear antibody (ANA) positive uveitis without systemic features
Participants must have active anterior uveitis
Participants must have an inadequate response or intolerance to MTX
Participants must be on a stable dose of corticosteroid eye drops
Participants and their partners must be willing to use two forms of birth control
Participants must NOT
Participants must not have of any autoimmune inflammatory condition other than JIA
Participants must not have had eye surgery within the 3 months
Participants must not have an infection
Participants must not have hepatitis B or tuberculosis (TB)
Trial Summary
Conditions the trial is for
Uveitis, Pediatric Uveitis
What the trial is testing?
Baricitinib, Adalimumab
Could I receive a Placebo?
no
Enrollment Goal
40
Trial Dates
October 2019 - December 2027
Trial Phase
3
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Participants must
Participants must have a diagnosis of JIA-U or chronic anterior antinuclear antibody (ANA) positive uveitis without systemic features
Participants must have active anterior uveitis
Participants must have an inadequate response or intolerance to MTX
Participants must be on a stable dose of corticosteroid eye drops
Participants and their partners must be willing to use two forms of birth control
Participants must NOT
Participants must not have of any autoimmune inflammatory condition other than JIA
Participants must not have had eye surgery within the 3 months
Participants must not have an infection
Participants must not have hepatitis B or tuberculosis (TB)
Trial Summary
Conditions the trial is for
Uveitis, Pediatric Uveitis
What the trial is testing?
Baricitinib, Adalimumab
Could I receive a Placebo?
no
Enrollment Goal
40
Trial Dates
October 2019 - December 2027
Trial Phase
3
Trial Locations
Hide locations not currently recruiting